TRA
MOLECULAR TARGETT cell receptor alpha locus
TRA (T cell receptor alpha locus) is targeted by 11 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TRA
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 1.10 | 2 |
| 2 | myricetin-3-O-galactopyranoside [Supplementary Concept] | 1.10 | 2 |
| 3 | Ethidium | 1.10 | 2 |
| 4 | Levodopa | 1.10 | 2 |
| 5 | Riboflavin Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. | 1.10 | 2 |
| 6 | Demeclocycline | 0.69 | 1 |
| 7 | Ethisterone 17 alpha-Hydroxypregn-4-en-20-yn-3-one. | 0.69 | 1 |
| 8 | Methyldopa | 0.69 | 1 |
| 9 | Ribitol | 0.69 | 1 |
| 10 | Sorbic Acid Mold and yeast inhibitor. Used as | 0.69 | 1 |
| 11 | Xylitol | 0.69 | 1 |
About TRA as a Drug Target
TRA (T cell receptor alpha locus) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 11 compounds with documented TRA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TRA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.